Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hacein-Bey-Abina

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Opinion in Hematology|October 18, 2001
Correction of genetic blood defects by gene transferM Cavazzana-Calvo, S Hacein-Bey-Abina
Hematology/Oncology Clinics of North America|January 18, 2011
Gene therapy for primary immunodeficienciesAlain Fischer, S Hacein-Bey-Abina, M Cavazzana-Calvo
Clinical Genetics|February 25, 2015
Gene therapy for primary immunodeficienciesA Fischer, S Hacein-Bey Abina, F Touzot, et al.
Annales De Biologie Clinique|March 30, 2004
[The bone marrow: a reserve of stem cells able to repair various tissues?]M Cavazzana-Calvo, C Lagresle, I André-Schmutz, et al.
Immunology and Allergy Clinics of North America|May 25, 2010
Gene therapy for primary immunodeficienciesAlain Fischer, S Hacein-Bey-Abina, M Cavazzana-Calvo, et al.
La Revue De Medecine Interne|May 30, 2021
Anti-Ma2 antibody encephalitis associated with Sjogren's syndromeK Chevalier, N Noel, F Benoudiba, et al.
Revue Neurologique|December 7, 2023
Impact of anti-PD-1 therapy in a melanoma patient with paraneoplastic anti-ITPR1 encephalitisF Brunet-Possenti, C Birzu, L Deschamps, et al.
Gene Therapy|March 3, 2006
Fragile sites are preferential targets for integrations of MLV vectors in gene therapyA C Bester, M Schwartz, M Schmidt, et al.
Bone Marrow Transplantation|April 13, 2004
Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donorsS Caillat-Zucman, F Le Deist, E Haddad, et al.
La Revue De Medecine Interne|August 10, 2021
L Pacoureau, C Labeyrie, P Catalan, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Opinion in Hematology|October 18, 2001
Correction of genetic blood defects by gene transferM Cavazzana-Calvo, S Hacein-Bey-Abina
Hematology/Oncology Clinics of North America|January 18, 2011
Gene therapy for primary immunodeficienciesAlain Fischer, S Hacein-Bey-Abina, M Cavazzana-Calvo
Clinical Genetics|February 25, 2015
Gene therapy for primary immunodeficienciesA Fischer, S Hacein-Bey Abina, F Touzot, et al.
Annales De Biologie Clinique|March 30, 2004
[The bone marrow: a reserve of stem cells able to repair various tissues?]M Cavazzana-Calvo, C Lagresle, I André-Schmutz, et al.
Immunology and Allergy Clinics of North America|May 25, 2010
Gene therapy for primary immunodeficienciesAlain Fischer, S Hacein-Bey-Abina, M Cavazzana-Calvo, et al.
La Revue De Medecine Interne|May 30, 2021
Anti-Ma2 antibody encephalitis associated with Sjogren's syndromeK Chevalier, N Noel, F Benoudiba, et al.
Revue Neurologique|December 7, 2023
Impact of anti-PD-1 therapy in a melanoma patient with paraneoplastic anti-ITPR1 encephalitisF Brunet-Possenti, C Birzu, L Deschamps, et al.
Gene Therapy|March 3, 2006
Fragile sites are preferential targets for integrations of MLV vectors in gene therapyA C Bester, M Schwartz, M Schmidt, et al.
Bone Marrow Transplantation|April 13, 2004
Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donorsS Caillat-Zucman, F Le Deist, E Haddad, et al.
La Revue De Medecine Interne|August 10, 2021
L Pacoureau, C Labeyrie, P Catalan, et al.
Pageof 2